Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Bob Langer - aVenture Research

Bob Langer

AddedMar 31, 2024

UpdatedOct 10, 2026

Bob Langer

Bob Langer

Co-Founder, SQZ Biotechnologies

Bob Langer's Career

SQZ Biotechnologies

Watertown, MA, US

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Co-Founder

Alnylam Pharmaceuticals aln

Cambridge, MA, US

Co-Founder

Moderna

Cambridge, MA, US

Co-Founder

Board Member· Board

Verseau Therapeutics

Bedford, MA, US

Co-Founder

Teal Bio

Somerville, MA, US

Co-Founder

Syntis Bio

Series B$15.4MMilton, MA, US

Co-Founder

Xenter

Series A$13MDraper, UT, US

Board Member· Board

Luminopia

Series A$33.1MCambridge, MA, US

Board Member· Board

Arsenal Medical

Watertown, MA, US

Board Member· Board

Co-Founder

Puretech Health PLC ORD 1P

Public$182.4MBoston, MA, US

Co-Founder

Board Member· Board

Lyra Therapeutics

Public$264.1MWatertown, MA, US

Board Member· Board

Seer

Public$169.5MRedwood City, CA, US

Board Member· Board

T2 Biosystems

$293.6MLexington, MA, US

Board Member· Board

Combinent Biomedical Systems

Lexington, MA, US

Board Member· Board

Co-Founder

Pervasis Therapeutics

$42MCambridge, MA, US

Board Member· Board

Perosphere

Series B$11.9MDanbury, CT, US

Board Member· Board

Predictive Biosciences

Series C$68.1MLexington, KY, US

Board Member· Board

Abpro

Public$42.4MWoburn, MA, US

Board Member· Board

Micell Technologies

$90.1MDurham, NC, US

Board Member· Board

Epi One

New York City, NY, US

Board Member· Board

People Similar to Bob Langer

Amy SchulmanBoard Member · Alnylam Pharmaceuticals aln

Mike BonneyBoard Member · Alnylam Pharmaceuticals aln

Phillip SharpCo-Founder · Biogen

Noubar AfeyanFounder · Life Technologies

John ClarkeBoard Member · Alnylam Pharmaceuticals aln

Paul SchimmelBoard Member · Longwood Fund

Kristina BurowBoard Member · AgTech Accelerator

Avak KahvejianFounder · Ampersand Biomedicines

David P. BartelCo-Founder · Alnylam Pharmaceuticals aln

Vicki SatoBoard Member · Allogene Therapeutics

Leadership at T2 Biosystems

Seymour LiebmanBoard Member

Tyler JacksCo-Founder

Lee JosephsonCo-Founder

Michael CimaCo-Founder

David AronoffBoard Member

John SperzelBoard Member

Similar to T2 Biosystems

Torus BiosystemsMedford, MA, USDiagnostics, Testingest. 2019Torus BiosystemsMedford, MA, US · est. 2019

Torus Biosystems: Advancing rapid DNA detection for infectious diseases through innovative molecular diagnostics.

Series A · $26.5M39

Leadership at Syntis Bio

Giovanni TraversoCo-Founder

Rahul DhandaCo-Founder

Similar to Syntis Bio

i2o TherapeuticsSaratoga, CA, USDrug Deliveryest. 2019i2o TherapeuticsSaratoga, CA, US · est. 2019

i2o Therapeutics: Innovating oral formulations for traditionally injectable therapies.

Series A · $90.4M15

Synereca PharmaceuticalsChapel Hill, NC, USDrugs, Pharmaceuticalsest. 2017Synereca PharmaceuticalsChapel Hill, NC, US · est. 2017

Synereca Pharmaceuticals innovates orally-active drugs to enhance existing antibiotics' effectiveness.

Pre-Seed · $2.3M6

Forward TherapeuticsPalm Beach Gardens, FL, USOral Therapiesest. 2022Forward TherapeuticsPalm Beach Gardens, FL, US · est. 2022

Forward Therapeutics: Innovating chronic inflammatory treatment through advanced oral immune therapies.

Series A · $50M2

Concours PharmaceuticalsTrenton, NJ, USPharmaceuticalsest. 2018Concours PharmaceuticalsTrenton, NJ, US · est. 2018

Concours Pharmaceuticals: Innovating oral drug delivery for advanced pharmaceutical development.

Seed · $2.7M30

Leadership at Xenter

Mark StautbergBoard Member

Rich LinderFounder

Similar to Xenter

XealthSeattle, WA, USAnalytics, Healthcareest. 2017XealthSeattle, WA, US · est. 2017

Xealth Inc.: A digital platform for health care information, ordering, and analytics.

Series B · $53.5M90

XableCathSalt Lake City, UT, USMedical Devicesest. 2013XableCathSalt Lake City, UT, US · est. 2013

Leading innovator and developer of medical devices, transforming concepts into market-ready products.

Pre-Seed · $1.2M30

CardieXItasca, IL, USHealthcare, Medical Devicesest. 2005CardieXItasca, IL, US · est. 2005

CardieX: A global health tech firm specializing in hypertension and cardiovascular disease solutions.

Public · $75k36

ReThink MedicalSan Francisco, CA, USMedical Devicesest. 2010ReThink MedicalSan Francisco, CA, US · est. 2010

San Francisco-based ReThink Medical develops wrist-worn devices to predict and prevent heart failure.

Series A · $5.5M2

Leadership at Luminopia

William DaiBoard Member

Mark JacobsteinBoard Member

Scott XiaoCo-Founder

Dean TraversBoard Member

Alex WendlandCo-Founder

Similar to Luminopia

LumiTheraPoulsbo, WA, USMedical Devicesest. 2013LumiTheraPoulsbo, WA, US · est. 2013

LumiThera, Inc.: Innovating non-invasive ocular devices for treating acute and chronic eye disorders.

Series C · $36.5M19

Leadership at Puretech Health PLC ORD 1P

Sharon Barber - LuiBoard Member

Joi ItoBoard Member

Christopher ViehbacherBoard Member

Daphne ZoharCo-Founder & CEO

Kiran Mazumdar-ShawBoard Member

Raju KucherlapatiBoard Member

Similar to Puretech Health PLC ORD 1P

Pliant TherapeuticsSouth San Francisco, CA, USTherapeuticsest. 2015Pliant TherapeuticsSouth San Francisco, CA, US · est. 2015

Pliant Therapeutics: A California-based biopharmaceutical company innovating therapies for fibrotic diseases.

Public · $694.9M124

Leadership at Lyra Therapeutics

Konstantin PoukalovBoard Member

Nancy SnydermanBoard Member

Paulina HillBoard Member

Maria BerkmanBoard Member

Dennis J DoughertyBoard Member

Maria PalasisCEO

Similar to Lyra Therapeutics

Lyric PharmaceuticalsSan Francisco, CA, USTherapeuticsest. 2013Lyric PharmaceuticalsSan Francisco, CA, US · est. 2013

Lyric, a clinical-stage company, innovates gastrointestinal therapeutics for unmet hospital needs.

Series A · $20.4M6

Leadership at Seer

Omid FarokhzadChief Executive Officer

David HallalBoard Member

Rachel HaurwitzBoard Member

Philip MaCo-Founder

Terry McguireBoard Member

John BirbeckBoard Member

Similar to Seer

Quantum-SiGuilford, CT, USProtein Sequencingest. 2013Quantum-SiGuilford, CT, US · est. 2013

Quantum-Si: A unique space empowering bright minds to solve tough problems and pioneer new science.

Public · $425M196

Leadership at Pervasis Therapeutics

Ed KaniaBoard Member

Yoram RichterBoard Member

Peter Barton HuttBoard Member

Similar to Pervasis Therapeutics

TheraVascCleveland, OH, USDrugs, Pharmaceuticalsest. 2009TheraVascCleveland, OH, US · est. 2009

TheraVasc Inc., a US pharmaceutical company, specializes in drugs for vascular diseases, particularly peripheral artery disease.

Public · $3.4M5

Permeon BiologicsCambridge, MA, USTherapeutic Drugsest. 2011Permeon BiologicsCambridge, MA, US · est. 2011

Cambridge-based Permeon Biologics develops therapeutic drugs to enhance human health.

Seed · $2.5M11

Vascular TherapiesCresskill, NJ, USBiopharmaceuticalsest. 2001Vascular TherapiesCresskill, NJ, US · est. 2001

Vascular Therapies: A biopharma company enhancing vascular surgery outcomes in kidney disease.

Series B · $90M7

VascugenMadison, WI, USCell Therapyest. 2017VascugenMadison, WI, US · est. 2017

Vascugen: Advancing iPSC therapy with engineered vascular cells for ischemic disease treatment.

Public · $10.8M11

Leadership at Perosphere

Sasha BakhruCo-Founder

Bryan LaulichtCo-Founder & CEO

Edith MathiowitzCo-Founder

Similar to Perosphere

Perosphere TechnologiesDanbury, CT, USMedical Devicesest. 2017Perosphere TechnologiesDanbury, CT, US · est. 2017

Perosphere Technologies: Innovating coagulation diagnostics and drug delivery systems for actionable healthcare.

Series A · $7.5M11

Resq PharmaceuticalHenderson, NV, USPharmaceuticalsest. 2019Resq PharmaceuticalHenderson, NV, US · est. 2019

RESQ Pharma, a stealth-mode pharmaceutical company based in Henderson, Nevada.

Series A · $8.8M5

Rho PharmaceuticalsGlen Mills, PA, USPharmaceuticalsest. 2016Rho PharmaceuticalsGlen Mills, PA, US · est. 2016

Innovative medical organization in Glen Mills, PA, developing enhanced drugs for early treatment of critical conditions.

Concours PharmaceuticalsTrenton, NJ, USPharmaceuticalsest. 2018Concours PharmaceuticalsTrenton, NJ, US · est. 2018

Concours Pharmaceuticals: Innovating oral drug delivery for advanced pharmaceutical development.

Seed · $2.7M30

Leadership at Predictive Biosciences

Michael GreeleyBoard Member

Dr M James Barrett "Jim"Board Member

MikeBoard Member

Similar to Predictive Biosciences

Pbs-BioMesa, AZ, USCancer Treatment, Pharmaceutical Researchest. 2006Pbs-BioMesa, AZ, US · est. 2006

Arizona-based Predictive Biomarker Sciences develops innovative cancer treatment technologies for pharmaceutical research.

Angel · $338.1k6

Leadership at Abpro

Ian ChanCo-Founder

Feng Ye "Frank"Board Member

Eugene ChanCo-Founder

Similar to Abpro

Global BioLos Angeles, CA, USAntibody Engineeringest. 2018Global BioLos Angeles, CA, US · est. 2018

GlobalBio: Pioneering therapeutic antibody engineering since 2014, based in Massachusetts.

AltruBioLos Altos, CA, USAntibody Therapeuticsest. 2000AltruBioLos Altos, CA, US · est. 2000

AltruBio, a global biotech firm, develops targeted antibody therapeutics for cancer and immune diseases.

Series B · $327.6M5

Abterra BiosciencesSan Diego, CA, USAntibody Therapeuticsest. 2009Abterra BiosciencesSan Diego, CA, US · est. 2009

Abterra Bio: Pioneering next-gen antibody therapeutics with advanced technology and machine learning.

AmagmaWaltham, MA, USAntibody Therapeuticsest. 2019AmagmaWaltham, MA, US · est. 2019

Biotech firm focused on developing antibody therapeutics to address clinical needs.

Series A · $18.6M12

Leadership at Micell Technologies

Jim McClainFounder

Kenneth LangoneBoard Member

Archie CoxBoard Member

Art BenvenutoBoard Member

Joe DesimoneBoard Member

Similar to Micell Technologies

Bioabsorbable TherapeuticsMenlo Park, CA, USMedical Devicesest. 2004Bioabsorbable TherapeuticsMenlo Park, CA, US · est. 2004

Bioabsorbable Therapeutics develops and commercializes medical devices for vascular diseases, using anti-inflammatory polymers.

Series B · $9.4M11

TB BiosciencesBethlehem, PA, USDiagnostic Testsest. 2013TB BiosciencesBethlehem, PA, US · est. 2013

TB Biosciences Inc. develops rapid, point-of-care diagnostic tests for active tuberculosis detection.

Series A · $1.5M30

YourBio HealthCambridge, MA, USMedical Devicesest. 2008YourBio HealthCambridge, MA, US · est. 2008

YourBio Health develops innovative products to simplify diagnostic medicine, enhancing blood sampling and testing.

Series C · $98.2M33

Tangen BiosciencesBranford, CT, USDNA Testing, Medical Instrumentsest. 2013Tangen BiosciencesBranford, CT, US · est. 2013

Tangen Biosciences: Pioneering DNA detection and medical instrument manufacturing since 2013.

Series A · $11M11

i-Lumen ScientificBloomington, MN, USMedical Devices, Therapeuticsest. 2015

i-Lumen ScientificBloomington, MN, US · est. 2015

i-Lumen Scientific: Innovating noninvasive therapies for dry age-related macular degeneration.

Series B · $18.8M5

Oui TherapeuticsNew Haven, CT, USDigital Therapeuticsest. 2018Oui TherapeuticsNew Haven, CT, US · est. 2018

Oui Health: Science-based digital therapeutics for managing mental health.

Series A · $26M12

OculoMotor TechnologiesNewark, DE, USDiagnostics, Vision Therapyest. 2018OculoMotor TechnologiesNewark, DE, US · est. 2018

Oculomotor Technologies: Providing vision therapy tools for optometry practices.

Purinomia BiotechWoburn, MA, USBiologicals, Drug Developmentest. 2017

Purinomia BiotechWoburn, MA, US · est. 2017

Purinomia Biotech: MA-based innovator in biologicals and drug development for diverse diseases.

Seed · $4.8M6

Permeon BiologicsCambridge, MA, USTherapeutic Drugsest. 2011Permeon BiologicsCambridge, MA, US · est. 2011

Cambridge-based Permeon Biologics develops therapeutic drugs to enhance human health.

Seed · $2.5M11

LiquidiaMorrisville, NC, USDrug Delivery, Therapeuticsest. 2004LiquidiaMorrisville, NC, US · est. 2004

Liquidia Technologies, a US-based biopharmaceutical firm, uses proprietary PRINT tech for developing human therapeutics.

Public · $415.9M75

LyndraWatertown, MA, USPharmaceuticals, Therapiesest. 2015

LyndraWatertown, MA, US · est. 2015

US-based Lyndra Therapeutics develops therapies for Alzheimer's, HIV, opioid use disorder, and schizophrenia.

Series E · $284.6M161

Cara TherapeuticsStamford, CT, USDrugs, Therapeuticsest. 2004Cara TherapeuticsStamford, CT, US · est. 2004

Cara Therapeutics, a Connecticut-based medical firm, develops novel drugs for pain and inflammation treatment.

Public · $517.2M106

Cyrano TherapeuticsDelray Beach, FL, USPharmaceuticals, Therapeuticsest. 2014Cyrano TherapeuticsDelray Beach, FL, US · est. 2014

Cyrano Therapeutics: Innovating intranasal solutions to restore taste and smell functions.

Series B · $21.8M7

Glyphic BiotechnologiesNew York City, NY, USProtein Sequencingest. 2021

Glyphic BiotechnologiesNew York City, NY, US · est. 2021

Glyphic: A global consulting firm providing innovative business solutions with Fortune 1000 companies using top tech platforms.

Angel · $10.6M25

Applied ProteomicsSan Diego, CA, USDiagnostic Testsest. 2006Applied ProteomicsSan Diego, CA, US · est. 2006

Applied Proteomics: Advancing proteomics with our protein biomarker discovery platform.

Series C · $54.5M32

EncodiaSan Diego, CA, USProtein Analysisest. 2015EncodiaSan Diego, CA, US · est. 2015

Encodia, a private biotech firm, revolutionizes proteomics with scalable protein analysis via ProteoCode technology.

Series C · $75M69

Castle BiosciencesFriendswood, TX, USCancer Testsest. 2008

Castle BiosciencesFriendswood, TX, US · est. 2008

Castle Biosciences, Inc.: A U.S. biotech firm offering diagnostic and prognostic cancer testing solutions.

Public · $354.3M543

Predictive Health Diagnostics CompanyIrvine, CA, USDiagnostic Testsest. 2017Predictive Health Diagnostics CompanyIrvine, CA, US · est. 2017

Predictive Health Diagnostics: Transforming data into intelligent, science-driven diagnostic tests.

Series A · $17.3M29

Urology DiagnosticsPortland, OR, USCancer Diagnosticsest. 2015Urology DiagnosticsPortland, OR, US · est. 2015

Genomics firm specializing in noninvasive, urine-based cancer diagnostics and monitoring.

Angel · $100k30

Medlogics DeviceSanta Rosa, CA, USMedical Devices, Stentsest. 2002

Medlogics DeviceSanta Rosa, CA, US · est. 2002

Medlogics Device Corp: US-based developer and manufacturer of cobalt alloy stents for coronary disease.

Public · $30M175

Neograft TechnologiesTaunton, MA, USMedical Devicesest. 2009Neograft TechnologiesTaunton, MA, US · est. 2009

Neograft Technologies: US-based biomedical device manufacturer specializing in coronary artery treatments.

Public · $39.3M30

Transluminal TechnologiesSyracuse, NY, USMedical Devicesest. 2008Transluminal TechnologiesSyracuse, NY, US · est. 2008

Transluminal Technologies: Innovating cardiovascular devices for swift patient recovery post-surgery.